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Background: Phospholipases C (PLCs) are virulence factors found in several bacteria. In Mycobacterium tuberculosis
(Mtb) they exhibit cytotoxic effects on macrophages, but the mechanisms involved in PLC-induced cell death are
not fully understood. It has been reported that induction of cell necrosis by virulent Mtb is coordinated by
subversion of PGE2, an essential factor in cell membrane protection.
Results: Using two Mtb clinical isolates carrying genetic variations in PLC genes, we show that the isolate 97-1505,
which bears plcA and plcB genes, is more resistant to alveolar macrophage microbicidal activity than the isolate
97-1200, which has all PLC genes deleted. The isolate 97-1505 also induced higher rates of alveolar macrophage
necrosis, and likewise inhibited COX-2 expression and PGE2 production. To address the direct effect of mycobacterial
PLC on cell necrosis and PGE2 inhibition, both isolates were treated with PLC inhibitors prior to macrophage infection.
Interestingly, inhibition of PLCs affected the ability of the isolate 97-1505 to induce necrosis, leading to cell death rates
similar to those induced by the isolate 97-1200. Finally, PGE2 production by Mtb 97-1505-infected macrophages was
restored to levels similar to those produced by 97-1200-infected cells.
Conclusions: Mycobacterium tuberculosis bearing PLCs genes induces alveolar macrophage necrosis, which is
associated to subversion of PGE2 production.
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Mycobacterium tuberculosis (Mtb), the causative agent
of tuberculosis, carries different virulence factors, which
allow proliferation of the pathogen in the host cell, cell-to-
cell spread, and evasion of immune response. Among the
most known virulence factors, phospholipases C (PLCs)
stand out in several intracellular bacteria, including
Clostridium perfringens, Corynebacterium pseudotubercu-
losis, Pseudomonas aeruginosa, Staphylococcus aureus,
and Listeria monocytogen [1-5]. The most virulent PLC
characterised to date is the α toxin (CPA) from Clostridium
perfringens exhibiting lethal, haemolytic, dermonecrotic,
vascular permeabilising, and platelet-aggregating properties* Correspondence: faccioli@fcfrp.usp.br
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unless otherwise stated.[2]. Thus, due to their role in the virulence mechanisms of
many bacterial pathogens, the relevance of PLCs during
mycobacterial infection has been the subject of investiga-
tion [6,7].
Mycobacterium tuberculosis PLCs are encoded by four
different genes [8]. Three of these genes, plc-A, plc-B, and
plc-C, are closely located, constituting an operon, whereas
plc-D is located in a different region [8,9]. Moreover, poly-
morphisms frequently affect PLC genes in Mtb, as obser-
ved in different clinical isolates [10].
The importance of PLC in mycobacterium virulence
was brought out by the demonstration that triple ΔplcABC
and quadruple ΔplcABCD Mtb mutants attenuated tuber-
culosis infection in mice [6]. In addition, it has been
previously shown that all Mtb PLCs present cytotoxic
effects on macrophages in vitro. Recombinant PLC
proteins expressed in M. smegmatis induced necrosisd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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into diacylglycerol (DAG) [7]. C. perfringens-PLC also
induces cell necrosis through releases of DAG from host
membrane by a mechanism dependent on activation of
PKC, MEK/ERK, and NFkB pathways, leading to high
concentrations of reactive oxygen species (ROS) and oxi-
dative stress [11].
An increasing number of studies have highlighted
the relationship between lipid mediators and cell
death. Also, subversion of host eicosanoid biosyn-
thetic pathways has been used as an evasion mechan-
ism by a virulent mycobacterium [12]. It has been
recently shown that infection with the attenuated Mtb
strain H37Ra resulted in abundant production of the
COX-2 product prostaglandin E2 (PGE2), and conse-
quently in activation of membrane repair mechanism.
On the other hand, the virulent strain H37Rv induces
the production of lipoxin A4 (LXA4), which is an inhibi-
tor of COX-2 expression and favours necrosis in infected
cells [13-15]. Thus, the lipid mediators PGE2 and LXA4
appear to exert opposing effects on Mtb-induced cell
death in macrophages. Another central lipid mediator
in Mtb infection is leukotriene B4 (LTB4). We have
previously shown that inhibition of leukotriene synthesis
increased susceptibility to mycobacterial infection and
pointed out alveolar macrophages as the main target
for immunostimulatory actions of LTB4 [16,17].
Given that mycobacterial PLCs have been associated
with cell death, in this study we investigated whether
this effect is related to the modulation of lipid mediator
production induced by PLCs. Using two Mtb clinical
isolates bearing genetic variations that affect PLC genes,
we investigated how PLCs affect the outcome of Mtb-
driven alveolar macrophage death and its relationship
with lipid mediator production.Figure 1 Intracellular killing of Mtb isolates 97-1200 or 97-1505 and c
were infected in vitro for 24 h with Mtb isolates 97-1200 or 97-1505 at MO
expressed as a percentage of phagocytised bacteria. (B) Cell viability assess
uninfected cells. (C) ELISA assay of apoptosis and necrosis 24 h post-infecti
was used as apoptosis-positive control and hypertonic buffer as necrosis-p
(97-1505 or 97-1200); ***P < 0.0001; **P < 0.001 (one-way ANOVA). Data are
(error bars, s.e.m.).Results
PLCs-expressing Mycobacterium tuberculosis is more
resistant to microbicidal activity and is associated with
alveolar macrophage death
The virulence phenotypes of the isolates 97-1200 and
97-1505 were compared regarding the resistance or sus-
ceptibility to alveolar macrophage microbicidal activity.
As shown in Figure 1A, after 24 hours of infection, the
isolate 97-1505 (presence of PLCs) was more resistant to
killing by alveolar macrophage than 97-1200 (absence of
PLCs). Considering that mycobacterial PLCs have cyto-
toxic effects on macrophages [7], we studied the viability
of rat alveolar macrophages infected in vitro with the
isolates 97-1200 or 97-1505 to investigate if cell death is
associated to mycobacterial PLCs. In comparison to
uninfected cells, mycobacterium isolate 97-1505 re-
duced cell viability by more than 40%, which was ap-
proximately 20% higher than the cell death induced
by 97-1200 (Figure 1B). Regarding the cell death modality,
alveolar macrophages infected with 97-1505 underwent
significantly more death by necrosis, and no differences
were observed in apoptosis induced by 97-1200 or
97-1505 isolates (Figure 1C). These results suggest
that Mtb bearing PLCs genes plays a role in host-cell
death by inducing necrosis, which contributes significantly
to mycobacterial resistance to microbicidal activity of
alveolar macrophages.
PLCs-expressing Mycobacterium tuberculosis more
efficiently stimulates the production of proinflammatory
cytokines and NO by alveolar macrophages in vitro
The results shown in Figure 1 indicate that the isolate
97-1505 is more resistant to bactericidal activity by
inducing host-cell necrosis. Thus, we next asked if the
production of pro-inflammatory cytokines and NO isell death of infected alveolar macrophages. Alveolar macrophages
I 5. (A) Bacterial killing was assessed by resazurin metabolisation and
ed by resazurin metabolisation. Maximum viability (100%) is based on
on of alveolar macrophages in vitro. Camptothecin 5 μg/mL (CAMP)
ositive control. #P < 0.0001 for uninfected cells vs. infected cells
representative of three (A, B) and two (C) independent experiments
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trol of Mtb infection [18]. In addition, previous data from
our lab revealed that lungs from mice infected with the
isolate 97-1505 presented extended tissue damage, which
was suggested to be associated with strong production
of pro-inflammatory cytokines (data not shown). Here,
in vitro infection showed that both isolates induced a
strong production of NO and the cytokines TNF-α, IL-6,
IL-1α, IL-1β, and IL-10. However, the amount of inflam-
matory cytokines and NO released in response to the
97-1505 isolate was significantly higher than that in-
duced by the 97-1200 isolate (Figure 2A and C). DespiteFigure 2 PLC-expressing Mycobacterium tuberculosis more efficiently
cytokines and NO2 in alveolar macrophages. Production of (A) the proin
by ELISA, and (C) NO, determined by Greiss reaction. (D) Quantification of ph
(Cytometric Bead Array), and expressed as U/ mL. # P < 0.0001 for uninfected
(one-way ANOVA). Data are representative of three (A–C) and two (D) indepethe increased production of IL-10, no difference was
observed between macrophages infected with the two dif-
ferent isolates (Figure 2B).
We also evaluated the ability of PLCs to activate
cell-signalling. Kinase proteins are directly associated
to cytokine production in pro-inflammatory cell responses
to bacterial stimulus [19], including Mtb [20]. Also,
considering that other bacterial PLCs were previously
reported to trigger host-cell signalling pathways [2,21], we
sought to verify if the mycobacterial isolates from this
study differentially activate cell-signalling proteins. Alveolar
macrophages infected with both Mtb isolates showedstimulates the cell activation, production of proinflammatory
flammatory cytokines TNF-α, IL-1α, IL-1β, and IL6; (B) IL-10, determined
osphorylated p38, ERK1/2, JNK1/2, and PLC-γ determined by CBA
cells vs. infected cells (97-1505 or 97-1200); ***P < 0.0001; *P < 0.05
ndent experiments (error bars, s.e.m.).
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protein kinases: MAPK p38, ERK1/2, and the c-Jun
N-terminal kinase JNK1/2. Notably, the isolate 97-1505
induced higher levels of kinase phosphorylation than
97-1200 after 30 minutes of bacteria–host cell contact.
On the other hand, host PLC-γ was not activated by either
isolate (Figure 2D). These data suggest that PLC, as a
mycobacterial virulence factor, plays a role in the cell acti-
vation and induction of proinflammatory cytokines by
alveolar macrophages.
PLCs-expressing Mycobacterium tuberculosis impaired
COX-2 and PGE2/LTB4 receptor mRNA expression
Virulent Mtb uses the control of host-cell death path-
ways as a strategy to avoid immune response through
subversion of host eicosanoid biosynthetic pathways
[14]. Thus, to investigate if the PLCs represent a virulence
advantage to the bacillus, we next evaluated the expres-
sion of mRNA for enzymes and receptors involved in the
eicosanoid synthesis, such as 5-lipoxygenase (5-LO), 5-LO
Activating Protein (FLAP), Leukotriene B4 (LTB4) receptor
(BLT1), cyclooxygenase-2 (COX-2), and the PGE2 recep-
tors EP-2 and EP-4. No differences were observed in 5-LO
or FLAP mRNA expression induced by the Mtb isolates.
On other hand, the isolate 97-1200 induced higher expres-
sion of BLT1 gene (Ltb4r), which is known to bind LTB4
and thus is related to antimicrobial defence (Figure 3C)
[16,17,22]. Differential expression was also observed forFigure 3 Differential mRNA expression of COX-2 and PGE2/LTB4 recep
expression of (A) 5-LO, FLAP, and BLT1, and (B) COX-2, EP-2, and EP-4 in al
and 97-1505. Dotted lines show the relative expression of uninfected cells
control. ***P < 0.0001; *P < 0.05 (one-way ANOVA). Data are representative ogenes related to the PGE2 synthesis pathway. During the
first hours of Mtb infection (6 h), the expression of the in-
ducible gene Ptgs2, which encodes COX-2, was higher in
response to the 97-1505 isolate. After 12 hours, although
the increased Ptgs2 expression was maintained, it was
lower than that induced by Mtb 97-1200. Associated with
COX-2 induction, gene expression of the prostaglandin
receptors EP-2 and EP-4 was also higher in alveolar mac-
rophages infected with 97-1200, 6 hours after infection
(Figure 3B). These findings suggest that PLCs-expressing
Mycobacterium tuberculosis subverts the eicosanoid syn-
thesis pathway by inhibiting COX-2, EP-2, and EP-4
expression, thereby directly influencing the generation of
PGE2 and its related cellular response.
Eicosanoid production is differentially induced by
PLC-expressing Mycobacterium tuberculosis during
alveolar macrophages infection
To study whether the modulation of COX-2 and eicosa-
noid receptor expression by the 97-1505 Mtb has effects
on the biosynthesis of these mediators, we quantified
PGE2 and LTB4 production by Mtb-infected alveolar
macrophages at different time points. Figure 4A shows
that 12 h after infection, PGE2 production induced by
97-1505 Mtb was similar to that induced by 97-1200
Mtb. However, after 24 h, 97-1505 Mtb-induced PGE2
production decreased drastically and remained lower at
48 h post-infection. Differently, 24 and 48 h after infection,tors induced by Mtb isolates 97-1200 and 97-1505. mRNA
veolar macrophages infected for 6 and 12 h with Mtb isolates 97-1200
(fold change = 1). All samples were normalised by Gapdh endongenous
f two independent experiments (error bars, s.e.m.).
Figure 4 LTB4 and PGE2 production by alveolar macrophages is differentially induced by PLC-expressing Mycobacterium tuberculosis.
Cells were infected with Mtb isolates 97-1200 or 97-1505 for 2, 12, 24, and 48 hours and the eicosanoid production was assessed in the supernatants
by ELISA. ***P < 0.0001; **P < 0.001 (one-way ANOVA). Data are representative of three (A) and two (B) independent experiments (error bars, s.e.m.).
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higher than that induced by 97-1200 (Figure 4B). To-
gether, our results support the idea that PLCs-expressing
Mtb are involved in decreased PGE2 production and lower
EP-2/4 gene expression, impairing eicosanoid-signalling
pathway in alveolar macrophages.
Cell death and subversion of PGE2 production are
dependent on mycobacterial PLCs
Thus far, our results showed that the Mtb isolate 97-
1505 induces necrotic death in alveolar macrophages,
which is associated with lower expression of COX-2 and
PGE2 receptors, leading to reduced production of PGE2,
compared with infection by 97-1200. We next examined
whether these effects are PLC-dependent. To do that, we
used the widely described PLC inhibitors D609 and
U73122 [23-25]. Thus, we pre-incubated both Mtb iso-
lates with PLC inhibitors (U73122 and D609) separately
or combined (Additional file 1: Figure S1), and analysed
the ability of the bacilli to cause necrosis and the effect on
PGE2 production. The treatment of Mtb isolates with PLC
inhibitors severely reduced necrosis of 97-1505-infected
cells, whereas it did not affect the necrosis of PLC-
deficient 97-1200-infected cells. Moreover, treatment with
PLC inhibitors had no effect on apoptosis induced by both
isolates (Figure 5A, B and Additional file 2: Figure S2A).
Likewise, PGE2 production by Mtb 97-1505-infected
alveolar macrophages presented levels similar to those
produced by 97-1200-infected cells, and PLC inhibition
did not affect the PGE2 production in cells infected
by 97-1200 (Figure 5C and Additional file 2: Figure S2B).
Finally, to address the role of PGE2 in cell death, celecoxib,
a COX-2 inhibitor, was added to the culture, which in-
creased necrosis rate in cells infected with both isolates.
On the other hand, addition of PGE2 prevented cell necro-
sis during infection with the isolate 97-1505 (Figure 5D
and Additional file 2: Figure S2C). Taken together, these
data reinforce that infection with Mtb harbouring PLCsinduces host-cell necrosis, which may be related to the
subversion of PGE2 synthesis.
Discussion
The central finding of this study was that PLC-
expressing Mycobacterium tuberculosis is more virulent
than Mtb lacking these enzymes, through inducing ne-
crosis of alveolar macrophages, which is associated to
subversion of PGE2 production. This is the first study to
demonstrate such a role for mycobacterial PLCs using
clinical isolates, which actually cause tuberculosis, instead
of models of recombinant expression of these enzymes in
non-pathogenic mycobacteria.
We showed that PLC-expressing Mtb (isolate 97-1505)
induced high rates of alveolar macrophage death, espe-
cially through necrosis, whereas the PLC-deficient Mtb
(isolate 97-1200), despite its ability to cause cell death,
did not induce necrosis as efficiently. Control of macro-
phage cell-death pathways by Mtb has been extensively
described as a strategy to avoid innate and adaptive im-
mune responses [12,26,27]. Manipulation of cell-death
modality has been successfully used by other intracellular
pathogens such as Chlamydia, Legionella pneumophila,
Listeria monocytogenes, Shigella flexineri, and Salmonella
enterica subsp. enterica serovar Typhimurium [28-30]. It
has been demonstrated that host-cell apoptosis confers
protection to the host, once the uptake of apoptotic bodies
derived from macrophages by dendritic cells allows an
effective activation of the immune response [31]. In con-
trast, host-cell necrosis can benefit the pathogen because
disruption of the cell membrane releases the bacteria to
efficiently spread and infect adjacent cells [32]. Recently,
descriptions of the manipulation of cell-death fate by Mtb
have shown that a virulent bacillus, the H37Rv strain,
caused macrophage necrosis whereas the attenuated strain
H37Ra was related to apoptotic death [12]. Likewise, a
Ndk- (nucleoside diphosphate kinase) knockout Mtb
showed reduced virulence, which was demonstrated by
Figure 5 PLC-expressing Mycobacterium tuberculosis induces alveolar macrophage necrosis through the regulation of PGE2 synthesis.
Alveolar macrophages were infected in vitro for 24 h with Mtb isolates 97-1200 or 97-1505 treated or not with the PLC inhibitors D609 (50 μM)
and U73122 (10 μM). (A, B) ELISA assay of apoptosis and necrosis. (C) PGE2 production was assessed in supernatants by ELISA. (D) Celecoxib or
PGE2 were added to the culture of alveolar macrophages infected or not with 97-1200 or 97-1505 and necrosis was assessed by ELISA.
#P < 0.0001 for
uninfected cells vs. infected cells (97-1505 or 97-1200); ***P < 0.0001; **P < 0.001 (one-way ANOVA). Data are representative of three (A, B) and two
(C, D) independent experiments (error bars, s.e.m.).
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increased ability to induce host-cell apoptosis [33].
Pulmonary macrophages are the primary niches for Mtb
replication, thus host resistance is critically dependent on
innate immune functions played by these cells. In this
scenario, proinflammatory cytokines and nitric oxide
(NO) are essential for host control of Mtb. Macrophage
recognition and phagocytosis of Mtb stimulates mostly
the production of TNF-α, IL-1α and β, and IL-6, which
are fundamental for the resolution of Mtb infection in
mice [18]. Our results highlighted the proinflammatory
response triggered by 97-1505 Mtb isolate, which induced
a higher production of those cytokines by alveolar macro-
phages than the isolate 97-1200. Surprisingly, the higher
production of proinflammatory cytokines did not result
in better outcome for the host cell, as shown by the
decreased macrophage survival. Stimulation of NO gen-
eration can cause oxidative stress leading to dysfunction
in mitochondrial respiration and also block caspase-3
activity by nitrosylation, which may inhibit apoptosis and
thereby promote necrosis [34]. Beyond the effects on the
immune response, TNF-α has been associated with necro-
sis in a caspase-independent mechanism through activa-
tion of receptor TNFR1 and engagement of RIP1 kinase
[34]. Recently, it was suggested that alveolar macrophagesinfected by an attenuated BCG (Bacillus Calmette–Guérin)
show high expression of the TNF-α-receptor TNFR1 asso-
ciated with increased cell apoptosis [35]. However, in that
particular study, only apoptosis rate was analysed and
necrosis was not shown. In addition, host-cell necrosis
induced by the T3SS pore-forming protein, YopB, from
pathogenic Yersinia has been associated with increased
production of proinflammatory cytokines, such as IL-1β
and TNF-α [36]. These findings support our data showing
that proinflammatory cytokines are involved in cell death
induced by intracellular bacteria.
Activation of the MAPK pathway has been directly
linked to cytokines production in proinflammatory cell
responses to bacterial stimulus [19], including Mtb [20].
In addition, MAP kinases have an essential role in pro-
duction of lipid mediators, such as LTB4, since activation
of 5-LO is dependent on phosphorylation mediated by
ERK1/2 and p38 [37]. In this study, higher phosphoryl-
ation of MAPK p38, ERK1/2, and JNK1/2 was observed
in cells infected with 97-1505. Although phosphorylation
of ERK1/2 and p38 can also be triggered by mammalian
PLCs, as demonstrated by LPS activation of the PLC–
PKC pathway [38], we observed no differences in PLC-γ
phosphorylation induced by the Mtb isolates 97-1200 or
97-1505 when compared to uninfected cells. Moreover,
Assis et al. BMC Microbiology 2014, 14:128 Page 7 of 10
http://www.biomedcentral.com/1471-2180/14/128different mycobacterial PLC isoforms can trigger MAPK
signalling by directly activating PKC through DAG pro-
duction from cell membrane phospholipids [7,39]. Based
on these findings, we hypothesise that the differential
activation of the MAPK pathway in 97-1505-Mtb-infected
alveolar macrophages may be due to mycobacterial
PLC actions.
Macrophages infected by mycobacteria increase the
production of LTB4 itself [17], which mediates host
immunopathology by enhancing Th1 responses and by
exacerbating inflammation [16,40]. LTB4 production in-
duced by both isolates in this study was considerably
amplified by PLCs; however, no significant differences
were observed at the early stages of infection, which
suggests that, besides PLCs, other mechanisms such as
the overproduction of proinflammatory cytokines can
contribute to immunopathology of Mtb infection. The
emergent knowledge that the balance in LTB4 produc-
tion is fundamental for the outcome of Mtb infection
points out that the excessive production of this lipid
mediator, associated to dysregulated production of TNF-α,
increases Mtb susceptibility in the zebrafish model, dem-
onstrated by necrosis of infected macrophages [41]. We
also found a lower production of PGE2 to be associated
with decreased mRNA expression of COX-2 and EP-2/4
receptors in Mtb 97-1505-infected alveolar macrophages.
Our group previously demonstrated that pharmacological
inhibition of COX-2 results in increase of LTB4 synthesis,
during Mtb infection in mice [17]. In the present study,
we show that addition of exogenous LTB4 to the culture
impairs PGE2 production by infected cells. These data are
in accordance with the concept of a shift in lipid mediator
production toward one eicosanoid subpathway [42], which
may explain the higher LTB4 and lower PGE2 production
observed here. Moreover, the finding that down-regulation
of PGE2 and higher necrosis were both impaired after
incubation of the isolate 97-1505 with PLC inhibitors,
supports the hypothesis that virulent mycobacterium sub-
verts eicosanoid synthesis to manipulate host-cell death to
promote proliferation and dissemination [15]. Here, when
exogenous PGE2 was added to 97-1505-infected alveolar
macrophages, the necrosis rate decreased. On the other
hand inhibition of PGE2 by celecoxib enhanced necrosis
in cells infected by both isolates. It has been reported that
PGE2-preventing necrosis is due to PGE2 involvement in
the synthesis of the lysossomal Ca2+ sensor SYT7, which
is essential for prevention of mitochondrial damage, enab-
ling repair of plasma membrane disruption [14]. Although
virulent mycobacteria sabotage of PGE2 to induce necrosis
has been associated with increased production of LXA4
[12,13,41], we did not detect LXA4 in the supernatant of
Mtb-infected alveolar macrophages (data not shown).
Nevertheless, the potential relationship between myco-
bacterial PLCs and host-cell necrosis through down-regulation of PGE2 production shown in this study is new
evidence of the relevance of this virulence factor.
Indeed, despite the described plc gene polymorphism
[10], there is no genome or proteome characterised for
either Mtb isolate, and further studies are necessary to
better understand the differences between 97-1505 and
97-1200, and the role of PLC in Mtb virulence. However,
our data make a valuable demonstration of subversion of
lipid mediator synthesis and its association with cell
necrosis. Furthermore, our data are consistent with the
recent finding of Bakala N’Goma and colleagues [7],
who showed for the first time the cytotoxic effect of
mycobacterial PLCs on macrophages. Finally, the rele-
vance of PLCs as determinants of virulence in Mtb
expands our understanding of how these virulence
factors can act to the detriment of the host, and highlights
eicosanoids, such as PGE2 and LTB4, as mediators with
functions that extend beyond innate immune mechanisms.
Conclusion
We found that the Mycobacterium tuberculosis bearing
PLCs genes is more resistant to microbicidal activity of
alveolar macrophages and induces cell necrosis, which is
associated with subversion of PGE2 production.
Methods
Mycobacterium tuberculosis isolates
The clinical isolates 97-1505 and 97-1200 were obtained
from patients with active tuberculosis in 1998 and belong
to a collection of 790 strains from RIVM (Bilthoven, The
Netherlands). Both isolates were characterised regarding
the polymorphisms in plc genes. The former has the entire
plc-A and plc-B genes and an insertion of a copy of
IS6110 at plc-C and the latter has all plc genes deleted.
Also, analysis of the RFLP (Restriction fragment length
polymorphism) pattern revealed similarities greater than
70% in the IS6110-RFLP profiles between the isolates [10].
Cultures were grown on Lowenstein-Jensen (LJ) solid
medium then transferred to Middlebrook 7H9 (Difco,
Detroit, MI) liquid medium supplemented with OADC
(Difco). The culture was harvested by centrifugation, and
the cell pellet was resuspended in sterile phosphate-
buffered saline (PBS) and the number of bacteria was ad-
justed to 1 × 107 bacteria/ mL by absorbance in DO600nm.
Viability of Mtb suspension was tested previously with
fluorescein diacetate and ethidium bromide (Sigma, St.
Louis, MO) [43] and by resazurin metabolisation within
24 h (Additional file 3: Figure S3A). In some experi-
ments, the Mtb isolates were pretreated with 10 μM
of U73122 (phosphatidylinositol-phospholipase C in-
hibitor (PI-PLC) – Calbiochem, San Diego, CA) and with
50 μM of D609 (phosphatidylcholine-specific phospholip-
ase C inhibitor (PC-PLC) – Calbiochem, San Diego, CA)
for 1 h at 37°C with agitation. To test the efficiency of
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fringens was used and the PLC activity was assessed by the
p-NPPC assay [44] (Additional file 4: Figure S4). After
that, all suspensions were centrifuged at 3,500 rpm for 10
min and washed twice with PRMI before addition to al-
veolar macrophage cultures. All experiments using myco-
bacterium isolates were conducted in a biosafety level 3
laboratory (BSL-3), according to permission of Brazilian
national authorities (registration number 003097).
Cell isolation, culture, and in vitro infection of alveolar
macrophages
Resident rat alveolar macrophages of > 95% purity were
obtained from ex vivo lung lavage [45] and resuspended
in RPMI 1640 at 2 × 106 cells/ml. Cells were adhered to
tissue culture-treated plates for 2 h (37°C, 5% CO2) and
were cultured overnight in RPMI containing 10% FBS
and 1% gentamicin. Before performing the experiments,
cells were washed two times with warm medium to re-
move nonadherent cells. Cells were infected with Mtb
isolates 98-1200 and 97-1505 at MOI 5 and incubated
for 2 h, followed by two washes and a further incubation
of cells in fresh medium for another 4, 10, 22, or 46
hours, depending on the experiment. In some experi-
ments, celecoxib (10 μM), PGE2 (1 μM), or LTB4 (1 μM)
were added to the cultures during Mtb infection. All ex-
periments were approved and conducted in accordance
with guidelines of the Animal Care Committee of Uni-
versidade de São Paulo (Protocol nº 11.1.252.53.3).
Measurement of eicosanoids, cytokines and NO
PGE2 and LTB4 concentrations in cell supernatants were
determined using ELISA EIA kits (Cayman Chemical,
Ann Arbor, MI). Cytokine concentrations were deter-
mined using a Duoset ELISA Development kit (R&D
Systems, Minneapolis, MN), according to the manufac-
turer’s recommendations. NO production was assessed
by detection of nitrite concentration in cell supernatants
using the Greiss reagent (0.1% NEED and 1% sulfanila-
mide). Values were determined using a standart curve
based in serial dilutions of NaNO2.
Resazurin assay of cell viability and bacterial killing
The resazurin assay has been used as a rapid test for evalu-
ating mammalian cell or microorganism viability and as a
cytotoxic susceptibility assay, in which the system incorpo-
rates an oxidation-reduction (REDOX) indicator, generating
a fluorescent metabolite [46]. Alveolar macrophages were
plated in 96-well dishes at 2 × 105 cells/well. After infection
time, 10 μL of a resazurin solution (0.5 mg/mL) (Sigma, St.
Louis, MO) was added to each well and cells were incu-
bated for 8 hours for viability evaluation (37°C, 5% CO2).
Fluorescence level was measured by a fluorescent micro-
plate reader (SpectraMax Paradigm, Molecular Devices,Sunnyvale, CA) with excitation at 560 nm and emission at
590 nm. To assess the bacterial killing, the Mtb isolates
were added at MOI 5 to alveolar macrophage cultures in
two 96-well plates. After 2 h of incubation, the supernatant
was removed and the cells washed three times with PBS to
remove non-phagocytised bacteria. In one of the plates,
cells were replenished with fresh medium and incubated
for a further 22 h. In the other plate, alveolar macrophages
were lysed using 200 μL of 0.05% saponin, then 10 μL of a
resazurin solution was added to each well and phagocytised
bacteria in suspension were incubated (37°C, 5% CO2) for
24 hours for further assessment of fluorescence level
(Additional file 3: Figure S3B). The remaining plate, after
24 h of incubation, was submitted to the same wash and
resazurin procedure. Bacterial killing was expressed as the
percentage relative to phagocytised bacteria.
In vitro necrosis and apoptosis assays
Evaluation of apoptosis and necrosis in alveolar macro-
phages was performed as previously described [14] by
ELISA assay cell (Cell Death Detection ELISAPLUS; 11
774425 001; Roche Applied Science, Mannheim, Germany),
which allows the quantification of cytoplasmic (apoptosis)
and extracellular (necrosis) histone-associated DNA frag-
ments. The relative amount of necrosis or apoptosis was
calculated as a ratio of the absorbance of infected macro-
phages to that of uninfected control macrophages. Camp-
tothecin (Sigma, St. Louis, MO) 5 μg/mL was used as
apoptosis-positive control and a hypertonic buffer (10 mM
Tris, pH 7.4; 400 mM NaCl; 5 mM CaCl2 and 10 mM
MgCl2) as necrosis-positive control.
Analysis of gene expression by real-time polymerase chain
reaction (PCR)
Total RNA was extracted from 4 × 106 alveolar macro-
phages using Trizol® reagent (Invitrogen) according to the
manufacturer’s instructions, and cDNA synthesis was per-
formed using the cDNA High Capacity Archive kit
(Applied Biosystems, Foster City, CA). Subsequently, the
mRNA expression was evaluated by real-time PCR using
the TaqMan® method. Briefly, the reaction mixture con-
tained 12.5 ng of cDNA, 5 μL of TaqMan® Universal PCR
Master Mix, and 0.5 μL of TaqMan specific primer/probe
(Applied Biosystems) in a 10 μL final volume reaction. For
each experiment, samples (n = 5-2) were run in duplicate.
The probes used for amplification were synthesised using
the Assay-on-Demand System (Applied Biosystems) with
the following GeneBank sequences: Ptgs2 (NM_017232.3),
Ptger2 (NM_031088.1), Ptger4 (NM_032076.3), Alox5
(NM_012822.1), Alox5ap (NM_017260.2) and Ltb4r
(NM_021656.1). The 2–ΔΔCT method was used in the ana-
lysis of the PCR data. First, the difference in gene expres-
sion was assessed between each gene and an endogenous
control (Gapdh) for each sample to generate the ΔΔCT.
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mined as follows: relative amount of target = 2–ΔΔCT
value. Uninfected alveolar macrophages were used as con-
trol samples and their average values were set as 1. The
relative gene expression for each experimental sample was
compared with this value.
Phosphoprotein detection by Cytometric Bead Array Flex Set
Samples were prepared according to the manufacturer’s
protocol for adherent cells (Becton Dickinson, Heidelberg,
Germany). Alveolar macrophages were stimulated by Mtb
isolates 97-1200 or 97-1505 for 30 minutes, 1 hour, and 2
hours. Addition of denaturation buffer halted activation of
cells and samples were placed immediately in a boiling
water bath for 5 min. Cell lysates were centrifuged at 14,000
rpm for 5 min and supernatants were stored at –80°C
until measurement of kinase phosphorylarion. Quantitative
determination of pJNK1/2 (T183/Y185), pp38 (T180/Y182),
pERK1/2 (T202/Y204), and pPLC-γ (Y783) was performed
using antibodies from the multiplex Flex Set Cytometric
Bead Array (Becton Dickinson, CA, USA). Afterwards,
mixed capture beads and PE detection reagent were added
to allow detection of phosphoprotein-antibody complexes.
Flow cytometric analysis was performed using FACSCanto
TM and a FACSDiva was used for data acquisition and ana-
lysis (Becton Dickinson, CA, USA). A total of 900 events
were acquired.
Statistical analysis
Data were evaluated by analysis of the variance (ANOVA)
between groups followed by the Turkey’s correction post-
test. In all comparisons, a significance level of P < 0.05 was
considered to be significant.
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